Dashboard
Manage Tickers

NUVANuvasive Inc


$ 39.80 $ -0.91 (-2.24 %)    

Thursday, 31-Aug-2023 15:59:49 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 455.25 $ 5.77 (1.29 %)
DIA $ 409.08 $ 4.58 (1.13 %)
SPY $ 546.60 $ 6.05 (1.12 %)
TLT $ 99.96 $ 0.43 (0.43 %)
GLD $ 231.58 $ 0.97 (0.42 %)
$ 39.75
-- x --
-- x --
-- - --
$ 35.17 - $ 49.53
31,368,558
na
na
$ 1.17
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Goosehead Insurance & Jackson Financial Se...
08/28/2023 21:19:05

Goosehead Insurance Inc. (NASD: GSHD) will replace NuVasive Inc. (NASD: NUVA) in the S&P SmallCap 600. Jackson Financial In...

morgan-stanley-maintains-equal-weight-on-nuvasive-raises-price-target-to-45
Morgan Stanley Maintains Equal-Weight on N...
08/04/2023 18:27:05

Morgan Stanley analyst Jonathan Demchick maintains NuVasive (NASDAQ:NUVA) with a Equal-Weight and raises the price target fr...

expert-ratings-for-nuvasive
Expert Ratings for NuVasive
08/04/2023 13:00:45

barclays-maintains-overweight-on-nuvasive-raises-price-target-to-58
Barclays Maintains Overweight on NuVasive,...
08/04/2023 11:08:06

Barclays analyst Matt Miksic maintains NuVasive (NASDAQ:NUVA) with a Overweight and raises the price target from $56 to $58.

nuvasive-sees-fy23-net-sales-growth-6-8
NuVasive Sees FY23 Net Sales Growth 6%-8%
08/02/2023 20:10:46

nuvasive-q2-eps-056-inline-sales-31780m-miss-32359m-estimate
NuVasive Q2 EPS $0.56, Inline, Sales $317....
08/02/2023 20:07:50

NuVasive (NASDAQ:NUVA) reported quarterly earnings of $0.56 per share which met the analyst consensus estimate. This is a 19.15...

earnings-scheduled-for-august-2-2023
Earnings Scheduled For August 2, 2023
08/02/2023 12:45:48

Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (NYSE:EDV) is estimated to report quarterly earn...

nuvasive-earnings-preview
NuVasive Earnings Preview
08/01/2023 19:01:44

truist-securities-maintains-hold-on-nuvasive-raises-price-target-to-51
Truist Securities Maintains Hold on NuVasi...
07/19/2023 13:51:48

Truist Securities analyst Richard Newitter maintains NuVasive (NASDAQ:NUVA) with a Hold and raises the price target from $48...

what-5-analyst-ratings-have-to-say-about-nuvasive
What 5 Analyst Ratings Have To Say About N...
05/31/2023 15:02:29

the-latest-analyst-ratings-for-nuvasive
The Latest Analyst Ratings for NuVasive
05/31/2023 12:09:10

morgan-stanley-maintains-equal-weight-on-nuvasive-lowers-price-target-to-40
Morgan Stanley Maintains Equal-Weight on N...
05/31/2023 11:39:03

Morgan Stanley analyst Jonathan Demchick maintains NuVasive (NASDAQ:NUVA) with a Equal-Weight and lowers the price target fr...

rbc-capital-reiterates-outperform-on-nuvasive-maintains-58-price-target
RBC Capital Reiterates Outperform on NuVas...
05/15/2023 12:54:43

RBC Capital analyst Shagun Singh reiterates NuVasive (NASDAQ:NUVA) with a Outperform and maintains $58 price target.

expert-ratings-for-nuvasive
Expert Ratings for NuVasive
05/12/2023 18:00:24

barclays-maintains-overweight-on-nuvasive-raises-price-target-to-56
Barclays Maintains Overweight on NuVasive,...
05/12/2023 10:05:06

Barclays analyst Matt Miksic maintains NuVasive (NASDAQ:NUVA) with a Overweight and raises the price target from $53 to $56.

rbc-capital-reiterates-outperform-on-nuvasive-maintains-58-price-target
RBC Capital Reiterates Outperform on NuVas...
05/11/2023 14:10:25

RBC Capital analyst Shagun Singh reiterates NuVasive (NASDAQ:NUVA) with a Outperform and maintains $58 price target.

morgan-stanley-maintains-equal-weight-on-nuvasive-lowers-price-target-to-43
Morgan Stanley Maintains Equal-Weight on N...
05/11/2023 12:27:58

Morgan Stanley analyst Jonathan Demchick maintains NuVasive (NASDAQ:NUVA) with a Equal-Weight and lowers the price target fr...

recap-nuvasive-q1-earnings
Recap: NuVasive Q1 Earnings
05/10/2023 21:10:35

nuvasive-reaffirms-fy23-net-sales-growth-of-6-8
NuVasive Reaffirms FY23 Net Sales Growth O...
05/10/2023 20:09:03

nuvasive-q1-adj-eps-047-beats-043-estimate-sales-30771m-beat-29822m-estimate
NuVasive Q1 Adj. EPS $0.47 Beats $0.43 Est...
05/10/2023 20:08:33

NuVasive (NASDAQ:NUVA) reported quarterly earnings of $0.47 per share which beat the analyst consensus estimate of $0.43 by 9.3...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION